In this review, we outline the molecular mechanisms of TGF-β biosynthesis, activation, and signal transduction, discuss its functions across various immune cell types, and summarize recent progress and challenges in clinical research on TGF-β targeted therapies for hematologic disorders, with the aim of providing new perspectives for related treatment strategies. The gene discussed is TGFB1; the disease is hematologic disorder.